newsfilter
← Latest News
Business Wire·

Catabasis Pharmaceuticals Reports Second Quarter 2019 Financial Results and Reviews Business Progress

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2019 and reviewed recent business progress.